Home » Moderna shares sink after leaked cancer data missed expectations

Moderna shares sink after leaked cancer data missed expectations

Httpsd1e00ek4ebabms cloudfront netproductionc9d40424 b91a 4240 ace5 fb485260daae

This post was originally published on this site.

Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations